GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,113,000 | +3.1% | 25,568 | +3.1% | 0.06% | +4.9% |
| Q1 2022 | $1,080,000 | +103.0% | 24,797 | +105.5% | 0.06% | +103.3% |
| Q4 2021 | $532,000 | +15.4% | 12,066 | 0.0% | 0.03% | -3.2% |
| Q3 2021 | $461,000 | -3.6% | 12,066 | +0.5% | 0.03% | -8.8% |
| Q2 2021 | $478,000 | +7.4% | 12,008 | -3.8% | 0.03% | -12.8% |
| Q1 2021 | $445,000 | -25.2% | 12,478 | -22.8% | 0.04% | -41.8% |
| Q4 2020 | $595,000 | -28.8% | 16,167 | -27.2% | 0.07% | -40.2% |
| Q3 2020 | $836,000 | -17.0% | 22,214 | -10.0% | 0.11% | -28.2% |
| Q2 2020 | $1,007,000 | +4.1% | 24,683 | -3.3% | 0.16% | -17.5% |
| Q1 2020 | $967,000 | -32.8% | 25,516 | -16.7% | 0.19% | -35.9% |
| Q4 2019 | $1,440,000 | +5.2% | 30,644 | -4.4% | 0.30% | +32.9% |
| Q3 2019 | $1,369,000 | +0.2% | 32,065 | -6.1% | 0.22% | -5.1% |
| Q2 2019 | $1,366,000 | +1.0% | 34,131 | +5.4% | 0.23% | -2.9% |
| Q1 2019 | $1,353,000 | – | 32,372 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |